Mark Plinio - Jun 14, 2021 Form 3 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Chief Commercial Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Mark D. Plinio
Stock symbol
EVLO
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/16/2021, 04:14 PM
Next filing
Jan 21, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney